C4 Therapeutics, Inc. (CCCC)
Nasdaq: CCCC · CIK 0001662579 · United States
Every official C4 Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CCCC filings
C4 Therapeutics, Inc. documents
- C4 Therapeutics, Inc. 10-K 2026CCCC 10-K 2026: annual report for fiscal 2026
- C4 Therapeutics, Inc. 10-K 2025CCCC 10-K 2025: annual report for fiscal 2025
- C4 Therapeutics, Inc. 10-K 2024CCCC 10-K 2024: annual report for fiscal 2024
- C4 Therapeutics, Inc. 10-K 2023CCCC 10-K 2023: annual report for fiscal 2023
- C4 Therapeutics, Inc. 10-K 2022CCCC 10-K 2022: annual report for fiscal 2022
- C4 Therapeutics, Inc. 10-Q 2026CCCC 10-Q 2026: quarterly report for fiscal 2026
- C4 Therapeutics, Inc. 10-Q 2025CCCC 10-Q 2025: quarterly report for fiscal 2025
- C4 Therapeutics, Inc. 10-Q 2024CCCC 10-Q 2024: quarterly report for fiscal 2024
- C4 Therapeutics, Inc. 10-Q 2023CCCC 10-Q 2023: quarterly report for fiscal 2023
- C4 Therapeutics, Inc. 10-Q 2022CCCC 10-Q 2022: quarterly report for fiscal 2022
- C4 Therapeutics, Inc. 8-K 2026CCCC 8-K 2026: current report for fiscal 2026
- C4 Therapeutics, Inc. 8-K 2025CCCC 8-K 2025: current report for fiscal 2025
- C4 Therapeutics, Inc. 8-K 2024CCCC 8-K 2024: current report for fiscal 2024
- C4 Therapeutics, Inc. 8-K 2023CCCC 8-K 2023: current report for fiscal 2023
- C4 Therapeutics, Inc. 8-K 2022CCCC 8-K 2022: current report for fiscal 2022
- C4 Therapeutics, Inc. DEF 14A 2026CCCC DEF 14A 2026: proxy statement for fiscal 2026
- C4 Therapeutics, Inc. DEF 14A 2025CCCC DEF 14A 2025: proxy statement for fiscal 2025
- C4 Therapeutics, Inc. DEF 14A 2024CCCC DEF 14A 2024: proxy statement for fiscal 2024
- C4 Therapeutics, Inc. DEF 14A 2023CCCC DEF 14A 2023: proxy statement for fiscal 2023
- C4 Therapeutics, Inc. DEF 14A 2022CCCC DEF 14A 2022: proxy statement for fiscal 2022
- C4 Therapeutics, Inc. Form 4 2026CCCC Form 4 2026: insider trading filing for fiscal 2026
- C4 Therapeutics, Inc. Form 4 2025CCCC Form 4 2025: insider trading filing for fiscal 2025
- C4 Therapeutics, Inc. Form 4 2024CCCC Form 4 2024: insider trading filing for fiscal 2024
- C4 Therapeutics, Inc. Form 4 2023CCCC Form 4 2023: insider trading filing for fiscal 2023
- C4 Therapeutics, Inc. Form 4 2022CCCC Form 4 2022: insider trading filing for fiscal 2022
- C4 Therapeutics, Inc. S-1 2026CCCC S-1 2026: registration statement for fiscal 2026
- C4 Therapeutics, Inc. S-1 2025CCCC S-1 2025: registration statement for fiscal 2025
- C4 Therapeutics, Inc. S-1 2024CCCC S-1 2024: registration statement for fiscal 2024
- C4 Therapeutics, Inc. S-1 2023CCCC S-1 2023: registration statement for fiscal 2023
- C4 Therapeutics, Inc. S-1 2022CCCC S-1 2022: registration statement for fiscal 2022
- C4 Therapeutics, Inc. 13F 2026CCCC 13F 2026: institutional holdings for fiscal 2026
- C4 Therapeutics, Inc. 13F 2025CCCC 13F 2025: institutional holdings for fiscal 2025
- C4 Therapeutics, Inc. 13F 2024CCCC 13F 2024: institutional holdings for fiscal 2024
- C4 Therapeutics, Inc. 13F 2023CCCC 13F 2023: institutional holdings for fiscal 2023
- C4 Therapeutics, Inc. 13F 2022CCCC 13F 2022: institutional holdings for fiscal 2022
More companies